Impact of influenza on hospitalization rates in children with a range of chronic lung diseases
- PMID: 30701672
- PMCID: PMC6468072
- DOI: 10.1111/irv.12633
Impact of influenza on hospitalization rates in children with a range of chronic lung diseases
Abstract
Background: Data on burden of severe influenza in children with a range of chronic lung diseases (CLDs) remain limited.
Method: We performed a cohort study to estimate burden of influenza-associated hospitalization in children with CLDs using population-based linked data. The cohort comprised all children in New South Wales, Australia, born between 2001 and 2010 and was divided into five groups, children with: (a) severe asthma; (b) bronchopulmonary dysplasia (BPD); (c) cystic fibrosis (CF); (d) other congenital/chronic lung conditions; and (e) children without CLDs. Incidence rates and rate ratios for influenza-associated hospitalization were calculated for 2001-2011. Average cost/episode of hospitalization was estimated using public hospital cost weights.
Results: Our cohort comprised 888 157 children; 11 058 (1.2%) had one of the CLDs. The adjusted incidence/1000 child-years of influenza-associated hospitalization in children with CLDs was 3.9 (95% CI: 2.6-5.2) and 0.7 (95% CI: 0.5-0.9) for children without. The rate ratio was 5.4 in children with CLDs compared to children without. The adjusted incidence/1000 child-years (95% CI) in children with severe asthma was 1.1 (0.6-1.6), with BPD was 6.0 (3.7-8.3), with CF was 7.4 (2.6-12.1), and with other congenital/chronic lung conditions was 6.9 (4.9-8.9). The cost/episode (95% CI) of influenza-associated hospitalization was AUD 19 704 (95% CI: 11 715-27 693) for children with CLDs compared to 4557 (95% CI: 4129-4984) for children without.
Discussion: This large population-based study suggests a significant healthcare burden associated with influenza in children with a range of CLDs.
Keywords: chronic lung diseases; influenza burden; pediatrics.
© 2019 The Authors. Influenza and Other Respiratory Viruses Published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors have no conflicts of interest relevant to this article to disclose.
Figures
References
-
- Freemantle N, Shallcross L, Kyte D, et al. Oseltamivir: the real world data. BMJ. 2014;348:g2371. - PubMed
-
- Poehling KA, Zhu Y, Tang YW, et al. Accuracy and impact of a point‐of‐care rapid influenza test in young children with respiratory illnesses. Arch Pediatr Adolesc Med. 2006;160:713‐718. - PubMed
-
- Sato M, Hosoya M, Kato K, et al. Viral shedding in children with influenza virus infections treated with neuraminidase inhibitors. Pediatr Infect Dis J. 2005;24:931‐932. - PubMed
-
- Neuzil KM, Wright PF, Mitchel EF Jr, et al. The burden of influenza illness in children with asthma and other chronic medical conditions. J Pediatr. 2000;137:856‐864. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
